Unsupervised mobile cognitive testing for use in preclinical Alzheimer's disease

Unsupervised mobile cognitive testing for use in preclinical Alzheimer's disease

Abstract Introduction Unsupervised digital cognitive testing is an appealing means to capture subtle cognitive decline in preclinical Alzheimer's disease (AD). Here, we describe development, feasibility, and validity of the Boston Remote Assessment for Neurocognitive Health (BRANCH) against in‐...

Full description

Bibliographic Details
Main Authors: Kathryn V. Papp, Aubryn Samaroo, Hsiang‐Chin Chou, Rachel Buckley, Olivia R. Schneider, Stephanie Hsieh, Daniel Soberanes, Yakeel Quiroz, Michael Properzi, Aaron Schultz, Iván García‐Magariño, Gad A. Marshall, Jane G. Burke, Raya Kumar, Noah Snyder, Keith Johnson, Dorene M. Rentz, Reisa A. Sperling, Rebecca E. Amariglio
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Subjects:
digital biomarkers
mobile testing
preclinical Alzheimer's disease
unsupervised assessment
Online Access:https://doi.org/10.1002/dad2.12243

Internet

https://doi.org/10.1002/dad2.12243

Similar Items